Medicine Experts

Dalia Megiddo

Executive Director
foamix pharmaceuticals
Smart Assays 


Dr. Dalia Megiddo is an experienced life-science and investment professional in the pharmaceutical and healthcare sectors. She has co-founded and served on the Board of Directors for a number of pharmaceutical companies, including Alcobra Ltd. (Nasdaq: ADHD) and Chiasma Ltd. (Nasdaq: CHMA). She currently serves as Managing Partner of Expedio Ventures, and previously ran other life science investment funds, including Jerusalem Global Ventures - InnoMed and 7-Health. Dr. Megiddo also co-founded Bioblast-Pharma Ltd. (Nasdaq: ORPN) and currently serves as a member of the company’s Board of Directors. Dr. Megiddo holds an M.D. in Medicine from Hebrew University, Jerusalem, and is a licensed specialist in family medicine. She also holds an M.B.A. degree from the Kellogg Recanati International School of Business (Tel Aviv University and North Western University).    

Research Interest

Pharmaceutical science 

Global Experts from Israel

Global Experts in Subject